These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24390725)

  • 21. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Funke-Kaiser A; Havulinna AS; Zeller T; Appelbaum S; Jousilahti P; Vartiainen E; Blankenberg S; Sydow K; Salomaa V
    Ann Med; 2014 May; 46(3):155-62. PubMed ID: 24506434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between biomarkers and left ventricular filling pressures at rest and during exercise in patients after myocardial infarction.
    Andersen MJ; Ersbøll M; Bro-Jeppesen J; Møller JE; Hassager C; Køber L; Borlaug BA; Goetze JP; Gustafsson F
    J Card Fail; 2014 Dec; 20(12):959-67. PubMed ID: 25285749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum copeptin and midregion proadrenomedullin (MR-proADM) after an ultramarathon.
    Lippi G; Schena F; Salvagno GL; Sanchis-Gomar F; Guidi GC
    J Clin Lab Anal; 2015 Jan; 29(1):15-20. PubMed ID: 24659530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptide kinetics and cardiopulmonary exercise testing in heart failure.
    Maeder M; Wolber T; Rickli H; Myers J; Hack D; Riesen W; Weilenmann D; Ammann P
    Int J Cardiol; 2007 Sep; 120(3):391-8. PubMed ID: 17182129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interface of hypothalamic-pituitary-adrenocortical axis and circulating brain natriuretic peptide in prediction of cardiopulmonary performance during physical stress.
    Popovic D; Popovic B; Plecas-Solarovic B; Pešić V; Markovic V; Stojiljkovic S; Vukcevic V; Petrovic I; Banovic M; Petrovic M; Vujisic-Tesic B; Ostojic MC; Ristic A; Damjanovic SS
    Peptides; 2013 Sep; 47():85-93. PubMed ID: 23876603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reference intervals and longitudinal changes in copeptin and MR-proADM concentrations during pregnancy.
    Joosen AMCP; van der Linden IJM; Schrauwen L; Theeuwes A; de Groot MJM; Ermens AAM
    Clin Chem Lab Med; 2017 Nov; 56(1):113-119. PubMed ID: 28672769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse Association Between Myocardial B-Type Natriuretic Peptide Release and Functional Capacity in Healthy Humans.
    Maeder MT; Thompson BR; Kaye DM
    Heart Lung Circ; 2018 Aug; 27(8):995-1003. PubMed ID: 28969979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.
    Wild PS; Schnabel RB; Lubos E; Zeller T; Sinning CR; Keller T; Tzikas S; Lackner KJ; Peetz D; Rupprecht HJ; Bickel C; Morgenthaler NG; Papassotiriou J; Tiret L; Münzel T; Blankenberg S
    Clin Chem; 2012 Jan; 58(1):226-36. PubMed ID: 22065157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
    Montrucchio G; Sales G; Rumbolo F; Palmesino F; Fanelli V; Urbino R; Filippini C; Mengozzi G; Brazzi L
    PLoS One; 2021; 16(2):e0246771. PubMed ID: 33556140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
    J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High plasma mid-regional pro-adrenomedullin levels in children with severe dengue virus infections.
    Michels M; Djamiatun K; Faradz SM; Koenders MM; de Mast Q; van der Ven AJ
    J Clin Virol; 2011 Jan; 50(1):8-12. PubMed ID: 20952250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea-a prospective intervention study.
    Karakioulaki M; Grendelmeier P; Strobel W; Schmid T; Jahn K; Grize L; Tamm M; Stolz D
    Respir Res; 2021 Apr; 22(1):114. PubMed ID: 33879148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients.
    Molvin J; Jujic A; Bachus E; Gallo W; Tasevska-Dinevska G; Holm H; Melander O; Fedorowski A; Magnusson M
    ESC Heart Fail; 2019 Oct; 6(5):992-999. PubMed ID: 31339668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
    Obokata M; Kane GC; Reddy YNV; Melenovsky V; Olson TP; Jarolim P; Borlaug BA
    Eur Heart J; 2019 Dec; 40(45):3707-3717. PubMed ID: 31513270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular biomarkers in paired maternal and umbilical cord blood samples at term and near term delivery.
    Blohm ME; Arndt F; Sandig J; Diehl W; Zeller T; Mueller GC; Schlesner C; Mir TS; Blankenberg S; Hecher K; Singer D; Weil J
    Early Hum Dev; 2016 Mar; 94():7-12. PubMed ID: 26851448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial.
    Truong QA; Siegel E; Karakas M; Januzzi JL; Bamberg F; Mahabadi AA; Dasdemir S; Brady TJ; Bergmann A; Kunde J; Nagurney JT; Hoffmann U; Koenig W
    Clin Chem; 2010 Apr; 56(4):651-60. PubMed ID: 20185624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
    Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H
    Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
    Adlbrecht C; Hülsmann M; Strunk G; Berger R; Mörtl D; Struck J; Morgenthaler NG; Bergmann A; Jakowitsch J; Maurer G; Lang IM; Pacher R
    Eur J Heart Fail; 2009 Apr; 11(4):361-6. PubMed ID: 19190023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Midregional pro-A-type natriuretic peptide for the evaluation of exercise intolerance.
    Maeder MT; Brutsche MH; Christ A; Staub D; Noveanu M; Breidthardt T; Schaub N; Potocki M; Reichlin T; Morgenthaler NG; Bergmann A; Mueller C
    Int J Cardiol; 2010 Nov; 145(2):326-328. PubMed ID: 20034689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.